The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses. Together with the online Statistical Bulletin and 30 Country Drug Reports, it makes up the 2019 European Drug Report package. This year’s report arrives at a critical time for reflection on drug policy developments, especially given the international debate on the appropriate follow-up to the United Nations special session on the world drug problem in 2016. Next year will see the final evaluation of the... current EU drugs strategy (2013-20). During this period, Europe has witnessed some dramatic changes in the challenges the drugs area presents, including the appearance of more non-controlled substances. We have also seen significant changes in the drug market and drug use; and our understanding of what constitutes effective interventions has increased. A market dominated by plant-based substances imported into Europe has evolved into one where synthetic drugs and production within Europe have grown in importance. Globalisation and technological advances have reshaped the strategic issues that European policymakers need to consider. We are proud of the EMCDDA’s international reputation for keeping pace with these changes and providing the information necessary to help support the cooperation and coordination that the EU drug strategy envisages.
Ix-xirja tiegħek fiha dan l-oġġett
Kien hemm żball waqt li kont qed iżżid prodott fix-xirja
You have already ordered this publication.
Il-verżjoni PDF hi b’xejn. Il-verżjoni li tiġi pprintjata fuq talba fiha spejjeż tal-ipprintjar u tal-posta, anki għal pubblikazzjonijiet bla ħlas. Dawn l-ispejjeż jistgħu jkunu ogħla mill-prezz tal-pubblikazzjoni.
> Il-verżjoni li tiġi pprintjata fuq talba tista’ tkun differenti fil-preżentazzjoni, il-kwalità mill-verżjoni oriġinali fuq il-karta.